Chinese consumers have a huge and growing appetite for supplements and functional foods, leading many manufacturers to consider international expansion, but strict and confusing routes to market can make this an all too costly endeavour.
This round-up looks at the latest findings from health and nutrition research, including the benefit of eicosapentaenoic acid (EPA) in lowering cardiovascular disease risk among diabetic patients, γ-tocopherol in reducing premenstrual symptoms such as...
The South Korean authorities have released a proposal on how oxidation should be measured in EPA and DHA products, in what is being seen as a move to bridge the gap between locally-made and imported products.
Omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are commonly associated with a reduced risk of coronary heart disease (CHD), but new research highlights how the ratio of EPA to DHA matter in influencing different...
A new lab partnership will help drive omega-3s research in the Asia Pacific region, according to OmegaQuant, a firm that has developed a simple blood test to measure levels of these important nutrients.
A database that includes 4,000-plus clinical trials on EPA and DHA omega-3s will help companies with claims substantiation, and provide ready access to significant scientific data to counter negative consumer media articles, says GOED’s executive director.
Omega-3 fats delivered using a proprietary self-micro-emulsifying system may be more bioavailable to the human body than the standard ethyl ester formulation, according to a new study funded by Pharmavite.
Results from an omega-3 study found a positive link between treatment using EPA and cardiovascular outcomes. It was backed by pharmaceutical company Amarin, which enjoyed a 300% surge in shares after the study results were announced.